fbpx

Year

2015
LEXINGTON, Mass., April 14, 2015 /PRNewswire/ -- scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today that it has elected Dorothy A. Coleman to its board of directors and that it has appointed Brian Piekos as Chief Financial Officer. 
The annual accounts for 2014 show a result of DKK 2.5 billion which is an increase of 20 percent compared to 2013. The Foundation also increased its distribution grants from DKK 376 million to DKK 474 million.
Niemann-Pick Disease experts Drs. Paul Gissen, Marc Patterson and Forbes D. Porter, along with biopharmaceutical industry leader Dr. Cristina Csimma, join Vtesse in quest to develop new treatments for people facing Niemann-Pick Disease Type C and rare diseasesGAITHERSBURG, Md., March 25, 2015 /PRNewswire/ -- Vtesse, Inc.,  a rare disease company focused on developing drugs for Niemann-Pick Disease...
SAN DIEGO and POMPEY, France, March 24, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage cardiovascular gene therapy company and Novasep, a leading supplier of services and technologies for the life sciences and chemical industries, today announce that they have signed a Development, Manufacturing and Supply Agreement pursuant to which, if supported by upcoming...
Cambridge, UK - 3rd March 2015: Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces that Scott Byrd and Christine Soden have joined its Board of Directors.
Lundbeck Foundation has hired Regitze Reeh (49) as the Foundation's first Communications Director. 
Lund, Sweden, (PRNEWSWIRE) February 25, 2015 - BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced that it has received regulatory approval from the CDSCO (Central Drugs Standards Control Organization) and their MDAC (Medical Device Approval Committee) to market CERAMENTT'BONE VOID FILLER and...
Recommendation of two new board members
LEXINGTON, Mass. /PRNewswire/ – scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today that Pieter Muntendam, President, CEO and founder of scPharmaceuticals, will present at Leerink Global Healthcare Conference in New York, NY on February 11, 2015. Dr. Muntendam will provide an update on the company beginning at 11:30...
1 4 5 6 7

News

Danish researchers provide proof: Caesarean sections can lead to asthma and allergies
12. November 2020
Brand-new medical treatment for cocaine addiction
10. November 2020
90 million to 18 Talented Researchers
19. October 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge